PATENT CLAIM ANALYSIS

Application Number: 15750128
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "412000"]

Abstract:
The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D 3  receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.

Claim (Index 4):
The compound of  claim 1 , wherein:\n W is C, O or S; R, R 1  and R 2  are hydrogen; G is a 6 member heteroaromatic ring or a phenyl optionally substituted by 1, 2 or 3 substituents selected from: halogen, cyano, C 1-4 alkyl, haloC 1-4 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy; Gi is an optionally substituted 5-6 membered heteroaromatic group Y is selected from the group consisting of: a saturated mono 3-7 membered carbocyclic group in which 0 or 1 or 2 carbon atoms are replaced by a heteroatom independently selected from O or NR 3 ; or a 5-6 membered heteroaromatic group, optionally substituted by one or two substituents selected from: hydroxyl, C 1-4 alkyl, and (CH 2 ) z C(\u2550O)N(R 4 R 5 ).

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15583679', '15272114', '13613344', '12664394', '11911035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8505229080629947
- 35 USC 102 Novelty (BERT): 0.5474751146351444
- Combined Prediction Score: 0.8202181287202096
- Mean Citation Score: 389.650642
- Max Citation Score: 434.1038
- Similarity Product: 293.64305298640727

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test